EB070

· Biotech Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EB070, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase Ia Single Ascending-Dose Study of Subcutaneous EB070 Injection in Healthy Volunteers [Phase 1]